Abstract:Background: The ε2, ε3 and ε4 alleles of apolipoprotein (APO) E gene constitute a common polymorphism in most populations, among which the APOEε4 allele is known to increase both the susceptibility and severity of Alzheimer's Disease (AD), and it is also associated with lipid profiles. High serum total cholesterol (TC) level in middle age has been proven to be a risk factor for AD and its related pathology. In addition, sex may alter the risk associated with the APOEε4 allele, and gender-specific APOE gene interactions can alter the response to anticholinesterase therapy. Therefore, sex is an important factor in studying the relationship between the APOE gene, lipid profiles and AD, and the underlying mechanism. However, there are few studies on whether there are differences in the effects of APOEε2 and APOEε4 on AD patients and healthy people of different genders, respectively.Material and methods: A total of 549 participants, including 298 AD patients and 251 body mass index (BMI)-matched health controls (HCs), were enrolled. Lipid profiles and APOE genes in both AD patients and matched controls were determined. The cognitive functions of the AD patients were evaluated using the Mini-mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA).Results: (1) The levels of TC and LDL in the AD group were higher than those in HCs. Subgroup analysis found that the AD patients with the APOEε4 allele had higher levels of TC and LDL than HCs carrying the APOEε4 allele, while in individuals without the APOEε4 allele. There was no significant difference in TG and HDL levels between the AD group and HCs. (2) The levels of TC and LDL in the APOEε4 carriers were higher than those in non-APOEε4 carriers. Subgroup analysis found that the increase of TC and LDL in the APOEε4 carriers was found in the AD and female populations, but not in HCs and male populations. (3) The levels of TC and LDL in the APOEε2 carriers were lower than those in non-APOEε2 carriers. Subgroup analysis found that the TC of APOEε2 carriers was lower than that of non-carriers in the male AD population, but not in the female AD population, female HCs, and male HCs. (4) The levels of TC, HDL and LDL in the female population were higher than the male population. (5) The increased LDL level may increase the risk of AD in female people carrying APOEε4.Conclusion: AD patients had higher TC and LDL levels than HCs, especially in the population with the APOEε4 allele. The levels of TC and LDL in the APOEε4 carriers were higher than those in non-APOEε4 carriers, especially in the female AD populations. The TC of APOEε2 carriers was lower than that of non-carriers, especially in male AD populations.

Biochemical Investigation of the Association of Apolipoprotein E Gene Allele Variations with Insulin Resistance and Amyloid-β Aggregation in Cardiovascular Disease.

Association of Apolipoprotein E (APOE) Polymorphisms With Serological Lipid and Inflammatory Markers

APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer’s disease and age-matched non-demented brains

The Impact of the Apolipoprotein E Genotype on Cardiovascular Disease and Cognitive Disorders

Investigation of the Relationship between Apolipoprotein E Alleles and Serum Lipids in Alzheimer's Disease: A Meta-Analysis

Peripheral metabolism of lipoprotein-amyloid beta as a risk factor for Alzheimer's disease: potential interactive effects of APOE genotype with dietary fats

APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics

The Application Value of ApoE Gene Polymorphism in Alzheimer's Disease

Effects of Apolipoprotein E Gene and Sex On Serum Lipid Profiles in Alzheimer's Disease

Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease

Deciphering ApoE Genotype-Driven Proteomic and Lipidomic Alterations in Alzheimer’s Disease Across Distinct Brain Regions

Role of Apolipoprotein E in Alzheimer's Disease Pathogenesis, Prognosis and Treatment

Effect of genetic polymorphism on apolipoprotein E glycosylation and lipoproteins metabolism

Multifaceted roles of APOE in Alzheimer disease

Apolipoprotein ε in Brain and Retinal Neurodegenerative Diseases

Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer's disease biomarkers

Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease

Effects of Sex on the Relationship Between Apolipoprotein E Gene and Serum Lipid Profiles in Alzheimer’s Disease

Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology

Expression of Apolipoprotein E in Alzheimer's Disease and Its Significance

The Relationship Between ApoE Gene Polymorphism and Lipid Parameters